145 related articles for article (PubMed ID: 7032945)
1. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM
Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945
[No Abstract] [Full Text] [Related]
2. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
[No Abstract] [Full Text] [Related]
3. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
[No Abstract] [Full Text] [Related]
4. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
Mouridsen HT; Palshof T; Engelsman E; Sylvester R
Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
[No Abstract] [Full Text] [Related]
5. Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials.
Palshof T; Mouridsen HT; Daehnfeldt JL
Eur J Cancer (1965); 1980; Suppl 1():183-7. PubMed ID: 7032931
[No Abstract] [Full Text] [Related]
6. Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial.
Westerberg H
Cancer Treat Rep; 1980 Jan; 64(1):117-21. PubMed ID: 6991101
[TBL] [Abstract][Full Text] [Related]
7. Preliminary report of a controlled trial in advanced breast cancer comparing tamoxifen with conventional hormone therapy.
Roberts HM; Forrest AP; Hamilton T; Langlands AO; Lutz W; McFadyen IJ; Stewart HJ
Cancer Treat Rep; 1976 Oct; 60(10):1461-2. PubMed ID: 798627
[No Abstract] [Full Text] [Related]
8. DES versus tamoxifen in advanced breast cancer.
N Engl J Med; 1981 Apr; 304(17):1041-3. PubMed ID: 7010171
[No Abstract] [Full Text] [Related]
9. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
Murayama Y
Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer.
Mouridsen H; Chaudri-Ross HA
Oncologist; 2004; 9(5):497-506. PubMed ID: 15477634
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
Ingle JN; Suman VJ; Mailliard JA; Kugler JW; Krook JE; Michalak JC; Pisansky TM; Wold LE; Donohue JH; Goetz MP; Perez EA
Breast Cancer Res Treat; 2006 Jul; 98(2):217-22. PubMed ID: 16538529
[TBL] [Abstract][Full Text] [Related]
14. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
15. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogen treatment of breast cancer: an overview.
Pearson OH; Manni A; Arafah BM
Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.
Ingle JN; Ahmann DL; Green SJ; Edmonson JH; Bisel HF; Kvols LK; Nichols WC; Creagan ET; Hahn RG; Rubin J; Frytak S
N Engl J Med; 1981 Jan; 304(1):16-21. PubMed ID: 7001242
[TBL] [Abstract][Full Text] [Related]
18. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer.
Cancer; 1978 Feb; 41(2):758-60. PubMed ID: 343913
[TBL] [Abstract][Full Text] [Related]
19. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability.
Mouridsen H; Sun Y; Gershanovich M; Perez-Carrion R; Becquart D; Chaudri-Ross HA; Lang R
Oncologist; 2004; 9(5):489-96. PubMed ID: 15477633
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen and breast cancer--from palliation to prevention.
Rich SE
Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]